These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 19300050

  • 21. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K, Nakamura S, Sugiyama T, Kadomatsu Y, Ueno H, Goto M, Ozeki N, Fukui T, Iwano S, Chen-Yoshikawa TF.
    BMC Cancer; 2021 Sep 02; 21(1):983. PubMed ID: 34474680
    [Abstract] [Full Text] [Related]

  • 22. F-18-FDG-avid lymph node metastasis along preferential lymphatic drainage pathways from the tumor-bearing lung lobe on F-18-FDG PET/CT in patients with non-small-cell lung cancer.
    Shigemoto Y, Suga K, Matsunaga N.
    Ann Nucl Med; 2016 May 02; 30(4):287-97. PubMed ID: 27007128
    [Abstract] [Full Text] [Related]

  • 23. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer.
    Nishiyama Y, Yamamoto Y, Kimura N, Ishikawa S, Sasakawa Y, Ohkawa M.
    Ann Nucl Med; 2008 May 02; 22(4):245-50. PubMed ID: 18535874
    [Abstract] [Full Text] [Related]

  • 24. Dual time point imaging for F18-FDG-PET/CT does not improve the accuracy of nodal staging in non-small cell lung cancer patients.
    Rogasch JM, Steffen IG, Riedel S, Apostolova I, Wertzel H, Achenbach HJ, Steinkrüger FL, Kalinski T, Schultz M, Schreiber J, Amthauer H, Furth C.
    Eur Radiol; 2016 Aug 02; 26(8):2808-18. PubMed ID: 26560731
    [Abstract] [Full Text] [Related]

  • 25. Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
    Satoh Y, Nambu A, Onishi H, Sawada E, Tominaga L, Kuriyama K, Komiyama T, Marino K, Aoki S, Araya M, Saito R, Maehata Y, Oguri M, Araki T.
    Eur J Radiol; 2012 Nov 02; 81(11):3530-4. PubMed ID: 22178287
    [Abstract] [Full Text] [Related]

  • 26. Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions.
    Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.
    Ann Nucl Med; 2009 Jul 02; 23(5):427-35. PubMed ID: 19437097
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
    Uesaka D, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Sasaki M, Fujibayashi Y, Okazawa H.
    J Nucl Med; 2008 Oct 02; 49(10):1606-12. PubMed ID: 18794269
    [Abstract] [Full Text] [Related]

  • 28. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.
    Clin Nucl Med; 2007 Aug 02; 32(8):607-12. PubMed ID: 17667432
    [Abstract] [Full Text] [Related]

  • 29. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
    Yang WF, Tan GZ, Fu Z, Yu JM.
    Zhonghua Zhong Liu Za Zhi; 2009 Dec 02; 31(12):925-8. PubMed ID: 20193335
    [Abstract] [Full Text] [Related]

  • 30. [18F]FAPI adds value to [18F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study.
    Li Y, Zhang Y, Guo Z, Hou P, Lv J, Ke M, Liu S, Li S, Yin W, He J, Wang X.
    Cancer Imaging; 2024 Jun 03; 24(1):68. PubMed ID: 38831354
    [Abstract] [Full Text] [Related]

  • 31. A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
    Pak K, Kim K, Kim MH, Eom JS, Lee MK, Cho JS, Kim YS, Kim BS, Kim SJ, Kim IJ.
    PLoS One; 2018 Jun 03; 13(2):e0193403. PubMed ID: 29486012
    [Abstract] [Full Text] [Related]

  • 32. Combination of Fluorine-18 Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography (¹⁸F-FDG PET/CT) and Tumor Markers to Diagnose Lymph Node Metastasis in Non-Small Cell Lung Cancer (NSCLC): A Retrospective and Prospective Study.
    Zhai X, Guo Y, Qian X.
    Med Sci Monit; 2020 Jun 02; 26():e922675. PubMed ID: 32483109
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic value of dual time-point 18 F-FDG PET/CT versus single time-point imaging for detection of mediastinal nodal metastasis in non-small cell lung cancer patients: a meta-analysis.
    Shen G, Hu S, Deng H, Jia Z.
    Acta Radiol; 2015 Jun 02; 56(6):681-7. PubMed ID: 24917609
    [Abstract] [Full Text] [Related]

  • 34. The value of net influx constant based on FDG PET/CT dynamic imaging in the differential diagnosis of metastatic from non-metastatic lymph nodes in lung cancer.
    Wumener X, Zhang Y, Zang Z, Ye X, Zhao J, Zhao J, Liang Y.
    Ann Nucl Med; 2024 Nov 02; 38(11):904-912. PubMed ID: 39078558
    [Abstract] [Full Text] [Related]

  • 35. [Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
    Su MG, Fan QP, Tian Y, Li FL, Yang XC, Li L, Fan CZ, Tian R.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May 02; 40(3):517-20. PubMed ID: 19627018
    [Abstract] [Full Text] [Related]

  • 36. The clinical value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in postoperative patients with gastrointestinal mucinous adenocarcinoma.
    Yang ZY, Hu SL, Shi W, Zhu BL, Xu JY, Zhang YJ.
    Nucl Med Commun; 2011 Nov 02; 32(11):1018-25. PubMed ID: 21956489
    [Abstract] [Full Text] [Related]

  • 37. Ratio between maximum standardized uptake value of N1 lymph nodes and tumor predicts N2 disease in patients with non-small cell lung cancer in 18F-FDG PET-CT scan.
    Honguero Martínez AF, García Jiménez MD, García Vicente A, López-Torres Hidalgo J, Colon MJ, van Gómez López O, Soriano Castrejón ÁM, León Atance P.
    Rev Esp Med Nucl Imagen Mol; 2016 Nov 02; 35(3):159-64. PubMed ID: 26514322
    [Abstract] [Full Text] [Related]

  • 38. Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
    Mallorie A, Goldring J, Patel A, Lim E, Wagner T.
    Nucl Med Commun; 2017 Aug 02; 38(8):715-719. PubMed ID: 28658052
    [Abstract] [Full Text] [Related]

  • 39. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients.
    Kim YK, Lee KS, Kim BT, Choi JY, Kim H, Kwon OJ, Shim YM, Yi CA, Kim HY, Chung MJ.
    Cancer; 2007 Mar 15; 109(6):1068-77. PubMed ID: 17311309
    [Abstract] [Full Text] [Related]

  • 40. Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.
    Okada M, Murakami T, Kumano S, Kuwabara M, Shimono T, Hosono M, Shiozaki H.
    Ann Nucl Med; 2009 Jan 15; 23(1):73-80. PubMed ID: 19205841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.